Modification effects of T2DM-susceptible SNPs on the reduction of blood glucose in response to lifestyle interventions
Received date: 2019-12-05
Revised date: 2020-02-26
Online published: 2020-03-01
Supported by
Supported by the National Natural Science Foundation of China No(81473038);Shanghai Leading Academic Discipline Project of Public Health No(15GWZX0801);Shanghai 3-Year Public Health Action Plan No(GWTD2015S04)
In recent years, it has been demonstrated that some susceptible gene loci of type 2 diabetes mellitus (T2DM) are not only associated with the susceptibility risk of T2DM, but also the modifying effects of lifestyle interventions. To further explore the modifying effects of the single nucleotide polymorphism (SNP) on the onset of T2DM and the reduction of blood glucose in response to lifestyle interventions among the high-risk population, we performed a lifestyle intervention study in two Deqing rural communities during the period from June to December in 2017. The intensive lifestyle interventions were conducted among the study subjects of the intervention group while those in the control group only received conventional and general health education. All participants were genotyped by the MassARRY system. This study showed that for SNP rs9502570, fasting blood glucose showed a significantly greater reduction for individuals with CC + CT genotype than those with TT genotype (P=0.031). In the intervention group, the glycated hemoglobin A1C (HbA1C) decreased by 0.03% for those with CC+CT genotype, while HbA1C increased by 0.27% for those with TT genotype (P=0.012). The difference in the reduction of fasting blood glucose and HbA1c between the intervention and control groups was also statistically significant between individuals with TT and those with CC+CT genotype. For SNP rs10811661, the reduction of fasting blood glucose was significantly higher in people with TT genotype than those with CC + CT genotype (0.44 mmol/L vs 0.12 mmol/L, P=0.021). The difference in reduction of fasting blood glucose between the intervention group and control group was also statistically significant between TT and CC+CT genotype (P<0.001). In summary, the SNP genotypes of both rs9502570 and rs10811661 could modify the effects of lifestyle interventions on reducing fasting blood glucose and HbA1C among the high risk rural population for T2DM. The present study has provided supporting evidence for future development of individualized intervention measures for high-risk population of T2DM.
Yuzhuo Wang, Yiming Zhang, Xiaolian Dong, Xuecai Wang, Jianfu Zhu, Na Wang, Feng Jiang, Yue Chen, Qingwu Jiang, Chaowei Fu . Modification effects of T2DM-susceptible SNPs on the reduction of blood glucose in response to lifestyle interventions[J]. Hereditas(Beijing), 2020 , 42(5) : 483 -492 . DOI: 10.16288/j.yczz.19-304
| [1] | Kaprio J, Tuomilehto J, Koskenvuo M, Romanov K, Reunanen A, Eriksson J, Steng?rd J, Kes?niemi YA . Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population- based cohort of twins in Finland. Diabetologia, 1992,35(11):1060-1067. |
| [2] | https://www.ebi.ac.uk/gwas/[EB/OL]. [2018.09]. |
| [3] | Kang JY, Sung SH, Lee YJ, Choi TI, Choi SJ . Impact of ENPP1 K121Q on change of insulin resistance after web-based intervention in korean men with diabetes and impaired fasting glucose. J Korean Med Sci, 2014,29(10):1353-1359. |
| [4] | Müssig K, Heni M, Thamer C, Kantartzis K, Machicao F, Stefan N, Fritsche A, H?ring HU, Staiger H . The ENPP1 K121Q polymorphism determines individual susceptibility to the insulin-sensitising effect of lifestyle intervention. Diabetologia, 2010,53(3):504-509. |
| [5] | Wang M, Pang C, Qu YL, Huang QY . Association and meta-analysis of ENPP1 K121Q with type 2 diabetes in Han Chinese. Hereditas(Beijing), 2010,32(8):808-816. |
| [5] | 王敏, 彭婵, 屈亚莉, 黄青阳 . 中国汉族人群ENPP1基因K121Q多态与2型糖尿病的关联及Meta分析. 遗传, 2010,32(8):808-816. |
| [6] | Haupt A, Thamer C, Heni M, Ketterer C, Machann J, Schick F, Machicao F, Stefan N, Claussen CD, H?ring HU, Fritsche A, Staiger H . Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetes. Diabetes, 2010,59(3):747-750. |
| [7] | Kim S, Misra A . SNP genotyping: technologies and biomedical applications. Annu Rev Biomed Eng, 2007,9(1):289-320. |
| [8] | Chinese Diabetes Society . Guidelines for the prevention and treatment of type 2 diabetes in China (2013 edition). Chin J Endocrinol Metabolism, 2014,30(10):893-942. |
| [8] | 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版). 中华内分泌代谢杂志, 2014,30(10):893-942. |
| [9] | Writing Group of 2018 Chinese Guidelines for the Management of Hypertension, Liu LS . 2018 Chinese guidelines for the management of hypertension. of 2018 Chinese Guidelines for the Management of Hypertension, Liu LS. 2018 Chinese guidelines for the management of hypertension. Prev Treat Cardio- Cerebr-Vascul Dis, 2019,19(1):1-44. |
| [9] | 《中国高血压防治指南》修订委员会, 刘力生 . 中国高血压防治指南2018年修订版. 心脑血管病防治, 2019,19(1):1-44. |
| [10] | Fu CW . The Deqing cohort study on type 2 diabetes of adults in rural communities of China[Dissertation]. Fudan University, 2010. |
| [10] | 付朝伟 . 农村社区成人2型糖尿病(德清队列)研究[学位论文]. 复旦大学, 2010. |
| [11] | Liu Y, Gen YM, Zhu YC . Chinese dietary guideline for residents evolution and enlightenments. Sichuan Sport Sci, 2017,36(4):21-25. |
| [11] | 刘越, 耿延敏, 朱亚成 . 中国《居民膳食指南》演变及启示. 四川体育科学, 2017,36(4):21-25. |
| [12] | Obesity Working Group of China. Guidelines for prevention and control of overweight and obesity in Chinese adults. Acta Nutri Sin, 2004,26(1):1-4. |
| [12] | 中国肥胖问题工作组. 中国成人超重与肥胖症预防与控制指南(节录). 营养学报, 2004,26(1):1-4. |
| [13] | Mahajan A, Taliun D, Thurner M, Robertson NR, Torres JM, Rayner NW, Payne AJ, Steinthorsdottir V, Scott RA, Grarup N, Cook JP, Schmidt EM, Wuttke M, Sarnowski C, M?gi R, Nano J, Gieger C, Trompet S, Lecoeur C, Preuss MH, Prins BP, Guo X, Bielak LF, Below JE, Bowden DW, Chambers JC, Kim YJ, Ng MCY, Petty LE, Sim X, Zhang W, Bennett AJ, Bork-Jensen J, Brummett CM, Canouil M, Ec Kardt KU, Fischer K, Kardia SLR, Kronenberg F, L?ll K, Liu CT, Locke AE, Luan J, Ntalla I, Nylander V, Sch?nherr S, Schurmann C, Yengo L, Bottinger EP, Brandslund I, Christensen C, Dedoussis G, Florez JC, Ford I, Franco OH, Frayling TM, Giedraitis V, Hackinger S, Hattersley AT, Herder C, Ikram MA, Ingelsson M, J?rgensen ME, J?rgensen T, Kriebel J, Kuusisto J, Ligthart S, Lindgren CM, Linneberg A, Lyssenko V, Mamakou V, Meitinger T, Mohlke KL, Morris AD, Nadkarni G, Pankow JS, Peters A, Sattar N, Stan?áková A, Strauch K, Taylor KD, Thorand B, Thorleifsson G, Thorsteinsdottir U, Tuomilehto J, Witte DR, Dupuis J, Peyser PA, Zeggini E, Loos RJF, Froguel P, Ingelsson E, Lind L, Groop L, Laakso M, Collins FS, Jukema JW, Palmer CNA, Grallert H, Metspalu A, Dehghan A, K?ttgen A, Abecasis GR, Meigs JB, Rotter JI, Marchini J, Pedersen O, Hansen T, Langenberg C, Wareham NJ, Stefansson K, Gloyn AL, Morris AP, Boehnke M , McCarthy MI. Fine-mapping type 2 diabetes loci to single-variant resolution using high- density imputation and islet-specific epigenome maps. Nat Genet, 2018,50(11):1505-1513. |
| [14] | Diabetes Genetics Replication And Meta-analysis(DIAGRAM) Consortium Asian Genetic Epidemiology Network Type 2 Diabetes(AGEN-T2D)Consortium; South Asian Type 2 Diabetes(SAT2D)Consortium Mexican American Type 2 Diabetes(MAT2D) Consortium, Type 2 Diabetes Genetic Exploration by Nex-generation sequencing in muylti-Ethnic Samples(T2D-GENES) Consortium, Mahajan A, Go MJ, Zhang W, Below JE, Gaulton KJ, Ferreira T, Horikoshi M, Johnson AD, Ng MC, Prokopenko I, Saleheen D, Wang X, Zeggini E, Abecasis GR, Adair LS, Almgren P, Atalay M, Aung T, Baldassarre D, Balkau B, Bao Y, Barnett AH, Barroso I, Basit A, Been LF, Beilby J, Bell GI, Benediktsson R, Bergman RN, Boehm BO, Boerwinkle E, Bonnycastle LL, Burtt N, Cai Q, Campbell H, Carey J, Cauchi S, Caulfield M, Chan JC, Chang LC, Chang TJ, Chang YC, Charpentier G, Chen CH, Chen H, Chen YT, Chia KS, Chidambaram M, Chines PS, Cho NH, Cho YM, Chuang LM, Collins FS, Cornelis MC, Couper DJ, Crenshaw AT, van Dam RM, Danesh J, Das D, de Faire U, Dedoussis G, Deloukas P, Dimas AS, Dina C, Doney AS, Donnelly PJ, Dorkhan M, van Duijn C, Dupuis J, Edkins S, Elliott P, Emilsson V, Erbel R, Eriksson JG, Escobedo J, Esko T, Eury E, Florez JC, Fontanillas P, Forouhi NG, Forsen T, Fox C, Fraser RM, Frayling TM, Froguel P, Frossard P, Gao Y, Gertow K, Gieger C, Gigante B, Grallert H, Grant GB, Grrop LC, Groves CJ, Grundberg E, Guiducci C, Hamsten A, Han BG, Hara K, Hassanali N, Hattersley AT, Hayward C, Hedman AK, Herder C, Hofman A, Holmen OL, Hovingh K, Hreidarsson AB, Hu C, Hu FB, Hui J, Humphries SE, Hunt SE, Hunter DJ, Hveem K, Hydrie ZI, Ikegami H, Illig T, Ingelsson E, Islam M, Isomaa B, Jackson AU, Jafar T, James A, Jia W, J?ckel KH, Jonsson A, Jowett JB, Kadowaki T, Kang HM, Kanoni S, Kao WH, Kathiresan S, Kato N, Katulanda P, Keinanen-Kiukaanniemi KM, Kelly AM, Khan H, Khaw KT, Khor CC, Kim HL, Kim S, Kim YJ, Kinnunen L, Klopp N, Kong A, Korpi-Hy?v?lti E, Kowlessur S, Kraft P, Kravic J, Kristensen MM, Krithika S, Kumar A, Kumate J, Kuusisto J, Kwak SH, Laakso M, Lagou V, Lakka TA, Langenberg C, Langford C, Lawrence R, Leander K, Lee JM, Lee NR, Li M, Li X, Li Y, Liang J, Liju S, Lim WY, Lind L, Lindgren CM, Lindholm E, Liu CT, Liu JJ, Lobbens S, Long J, Loos RJ, Lu W, Luan J, Lyssenko V, Ma RC, Maeda S, M?gi R, M?nnisto S, Matthews DR, Meigs JB, Melander O, Metspalu A, Meyer J, Mirza G, Mihailov E, Moebus S, Mohan V, Mohlke KL, Morris AD, Mühleisen TW, Müller-Nurasyid M, Musk B, Nakamura J, Nakashima E, Navarro P, Ng PK, Nica AC, Nilsson PM, Nj?lstad I, N?then MM, Ohnaka K, Ong TH, Owen KR, Palmer CN, Pankow JS, Park KS, Parkin M, Pechlivanis S, Pedersen NL, Peltonen L, Perry JR, Peters A, Pinidiyapathirage JM, Platou CG, Potter S, Price JF, Qi L, Radha V, Rallidis L, Rasheed A, Rathman W, Rauramaa R, Raychaudhuri S, Rayner NW, Rees SD, Rehnberg E, Ripatti S, Robertson N, Roden M, Rossin EJ, Rudan I, Rybin D, Saaristo TE, Salomaa V, Saltevo J, Samuel M, Sanghera DK, Saramies J, Scott J, Scott LJ, Scott RA, Segrè AV, Sehmi J, Sennblad B, Shah N, Shah S, Shera AS, Shu XO, Shuldiner AR, Sigur?sson G, Sijbrands E, Silveira A, Sim X, Sivapalaratnam S, Small KS, So WY, Stan?áková A, Stefansson K, Steinbach G, Steinthorsdottir V, Stirrups K, Strawbridge RJ, Stringham HM, Sun Q, Suo C, Syv?nen AC, Takayanagi R, Takeuchi F, Tay WT, Teslovich TM, Thorand B, Thorleifsson G, Thorsteinsdottir U, Tikkanen E, Trakalo J, Tremoli E, Trip MD, Tsai FJ, Tuomi T, Tuomilehto J, Uitterlinden AG, Valladares-Salgado A, Vedantam S, Veglia F, Voight BF, Wang C, Wareham NJ, Wennauer R, Wickremasinghe AR, Wilsgaard T, Wilson JF, Wiltshire S, Winckler W, Wong TY, Wood AR, Wu JY, Wu Y, Yamamoto K, Yamauchi T, Yang M, Yengo L, Yokota M, Young R, Zabaneh D, Zhang F, Zhang R, Zheng W, Zimmet PZ, Altshuler D, Bowden DW, Cho YS, Cox NJ, Cruz M, Hanis CL, Kooner J, Lee JY, Seielstad M, Teo YY, Boehnke M, Parra EJ, Chambers JC, Tai ES, McCarthy MI, Morris AP. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet, 2014,46(3):234-244. |
| [15] | Kasuga K, Hata K, Tajima A, Ochiai D, Saisho Y, Matsumoto T, Arata N, Miyakoshi K, Tanaka M . Association of common polymorphisms with gestational diabetes mellitus in Japanese women: A case-control study. Endocr J, 2017,64(4):463-475. |
| [16] | Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 2007,447(7145):661-678. |
| [17] | Broadbent HM1, Peden JF, Lorkowski S, Goel A, Ongen H, Green F, Clarke R, Collins R, Franzosi MG, Tognoni G, Seedorf U, Rust S, Eriksson P, Hamsten A, Farrall M, Watkins H . Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet, 2008,17(6):806-814. |
| [18] | Cugino D, Gianfagna F, Santimone I, de Gaetano G, Donati MB, Iacoviello L, Di Castelnuovo A. Type 2 diabetes and polymorphisms on chromosome 9p21: a meta-analysis. Nutr Metab Cardiovasc Dis, 2012,22(8):619-625. |
| [19] | Emanuele E, Lista S, Ghidoni R, Binetti G, Cereda C, Benussi L, Maletta R, Bruni AC, Politi P . Chromosome 9p21.3 genotype is associated with vascular dementia and Alzheimer's disease. Neurobiol Aging, 2011,32(7):1231-1235. |
| [20] | Burdon KP, Macgregor S, Hewitt AW, Sharma S, Chidlow G, Mills RA, Danoy P, Casson R, Viswanathan AC, Liu JZ, Landers J, Henders AK, Wood J, Souzeau E, Crawford A, Leo P, Wang JJ, Rochtchina E, Nyholt DR, Martin NG, Montgomery GW, Mitchell P, Brown MA, Mackey DA, Craig JE . Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1. Nat Genet, 2011,43(6):574-578. |
| [21] | Schaefer AS, Richter GM, Groessner-Schreiber B, Noack B, Nothnagel M, El Mokhtari NE, Loos BG, Jepsen S, Schreiber S . Identification of a shared genetic susceptibility locus for coronary heart disease and periodontitis. PLoS Genet, 2009,5(2):e1000378. |
| [22] | Duesing K, Fatemifar G, Charpentier G, Marre M, Tichet J, Hercberg S, Balkau B, Froguel P, Gibson F , Strong association of common variants in the CDKN2A/ CDKN2B region with type 2 diabetes in French Europids. Diabetologia, 2008,51(5):821-826. |
| [23] | Takeuchi F, Serizawa M, Yamamoto K, Fujisawa T, Nakashima E, Ohnaka K, Ikegami H, Sugiyama T, Katsuya T, Miyagishi M, Nakashima N, Nawata H, Nakamura J, Kono S, Takayanagi R, Kato N . Confirmation of multiple risk Loci and genetic impacts by a genome- wide association study of type 2 diabetes in the Japanese population. Diabetes, 2009,58(7):1690-1699. |
| [24] | Wu Y, Li HX, Loos RJF, Yu ZJ, Ye XW, Chen LH, Pan A, Hu FB, Lin X . Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes, 2008,57(10):2834-2842. |
| [25] | Steinthorsdottir V, Thorleifsson G, Reynisdottir I, Benediktsson R, Jonsdottir T, Walters GB, Styrkarsdottir U, Gretarsdottir S, Emilsson V, Ghosh S, Baker A, Snorradottir S, Bjarnason H, Ng MC, Hansen T, Bagger Y, Wilensky RL, Reilly MP, Adeyemo A, Chen Y, Zhou J, Gudnason V, Chen G, Huang H, Lashley K, Doumatey A, So WY, Ma RC, Andersen G, Borch-Johnsen K, Jorgensen T, van Vliet-Ostaptchouk JV, Hofker MH, Wijmenga C, Christiansen C, Rader DJ, Rotimi C, Gurney M, Chan JC, Pedersen O, Sigurdsson G, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet, 2007,39(6):770-775. |
/
| 〈 |
|
〉 |
www.chinagene.cn
备案号：京ICP备09063187号
